U.S. Drug Retail Industry Analysis
UpdatedMay 29, 2023
DataAggregated Company Financials
Companies11
- 7D-4.1%
- 3M-15.5%
- 1Y-31.3%
- YTD-19.5%
Over the last 7 days, the Drug Retail industry has dropped 4.1%, driven by Walgreens Boots Alliance declining 3.8%. On the other hand MedAvail Holdings is actually up 6.1%. Overall the industry is down 31% in 12 months. Earnings are forecast to grow by 52% annually.
Industry Valuation and Performance
Has the U.S. Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 29 May 2023 | US$26.2b | US$135.5b | -US$3,272,241,937.00 | n/a | -8x | 0.2x |
| Wed, 26 Apr 2023 | US$30.4b | US$135.5b | -US$3,266,127,301.00 | n/a | -9.3x | 0.2x |
| Fri, 24 Mar 2023 | US$28.3b | US$134.3b | -US$3,078,202,251.00 | n/a | -9.2x | 0.2x |
| Sun, 19 Feb 2023 | US$32.0b | US$134.3b | -US$3,076,604,765.00 | n/a | -10.4x | 0.2x |
| Tue, 17 Jan 2023 | US$32.0b | US$134.3b | -US$3,078,064,410.00 | n/a | -10.4x | 0.2x |
| Thu, 15 Dec 2022 | US$35.4b | US$134.8b | US$4.2b | 8.1x | 8.4x | 0.3x |
| Sat, 12 Nov 2022 | US$36.0b | US$134.7b | US$4.2b | 8.2x | 8.6x | 0.3x |
| Mon, 10 Oct 2022 | US$26.7b | US$136.5b | US$5.0b | 5.2x | 5.4x | 0.2x |
| Wed, 07 Sep 2022 | US$30.9b | US$136.6b | US$5.0b | 6x | 6.2x | 0.2x |
| Fri, 05 Aug 2022 | US$34.0b | US$136.6b | US$5.0b | 6.6x | 6.8x | 0.2x |
| Sun, 03 Jul 2022 | US$33.6b | US$136.6b | US$5.0b | 6.5x | 6.8x | 0.2x |
| Tue, 31 May 2022 | US$38.0b | US$138.0b | US$5.8b | 6.4x | 6.6x | 0.3x |
| Thu, 28 Apr 2022 | US$38.5b | US$138.1b | US$5.8b | 44.9x | 6.7x | 0.3x |
| Sat, 26 Mar 2022 | US$41.5b | US$161.5b | US$5.6b | 6.8x | 7.4x | 0.3x |
| Mon, 21 Feb 2022 | US$41.1b | US$161.4b | US$5.6b | 6.7x | 7.3x | 0.3x |
| Wed, 19 Jan 2022 | US$47.2b | US$161.4b | US$5.6b | 7.7x | 8.4x | 0.3x |
| Fri, 17 Dec 2021 | US$43.6b | US$158.8b | US$1.7b | 21.3x | 25.8x | 0.3x |
| Sun, 14 Nov 2021 | US$44.2b | US$158.7b | US$1.7b | 21.5x | 25.8x | 0.3x |
| Tue, 12 Oct 2021 | US$42.4b | US$172.3b | US$2.0b | 18.2x | 21.5x | 0.2x |
| Thu, 09 Sep 2021 | US$45.5b | US$172.2b | US$2.1b | 19.4x | 22.2x | 0.3x |
| Sat, 07 Aug 2021 | US$41.6b | US$148.0b | US$2.1b | 18.1x | 19.8x | 0.3x |
| Fri, 30 Apr 2021 | US$47.5b | US$144.1b | -US$775,834,974.59 | n/a | -61.2x | 0.3x |
| Mon, 01 Feb 2021 | US$44.8b | US$142.5b | -US$824,820,977.24 | n/a | -54.3x | 0.3x |
| Thu, 05 Nov 2020 | US$30.1b | US$140.7b | US$373.2m | 37.5x | 80.7x | 0.2x |
| Sun, 09 Aug 2020 | US$35.9b | US$126.5b | US$416.7m | 37.1x | 86.2x | 0.3x |
Price to Earnings Ratio
94.7x
Current Industry PE
- Investors are pessimistic on the American Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.26x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 2.3% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does U.S. Drug Retail compare with similar industries?
| US Market | 0.35% | |
| Consumer Staples | -3.04% | |
| Food and Staples Retail | -2.44% | |
| Drug Retail | -4.10% | |
| Big Box Super Stores | -2.29% | |
| Food Distributors | -2.67% | |
| Food Retail | -3.26% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MDVL MedAvail Holdings | US$0.22 | 6.1% +US$1.0m | -87.0% | PS0.4x | |
| CJJD China Jo-Jo Drugstores | US$0.74 | 1.7% +US$258.6k | -62.8% | PS0.09x |